Valuation: Enovis Corporation

Market Cap 1.22B 1.09B 1B 909M 1.7B 115B 1.73B 12.07B 4.78B 60.46B 4.56B 4.47B 191B P/E 2026 *
104x
P/E 2027 * 32.2x
Enterprise Value 2.52B 2.25B 2.08B 1.89B 3.53B 239B 3.59B 25.04B 9.91B 125B 9.46B 9.26B 395B EV / Sales 2026 *
1.08x
EV / Sales 2027 * 1x
Free-Float
98.36%
Yield 2026 *
-
Yield 2027 * -
1 day-0.62%
1 week+5.64%
Current month+14.89%
1 month+15.58%
3 months-25.70%
6 months-14.47%
Current year-21.21%
1 week 19.89
Extreme 19.89
21.73
1 month 16.7
Extreme 16.7
21.73
Current year 16.7
Extreme 16.7
31.66
1 year 16.7
Extreme 16.7
34.28
3 years 16.7
Extreme 16.7
65.03
5 years 16.7
Extreme 16.7
164.01
10 years 16.7
Extreme 16.7
164.01
Manager TitleAgeSince
Chief Executive Officer 61 11/05/2025
Director of Finance/CFO 47 31/12/2022
Chief Tech/Sci/R&D Officer - 31/12/2025
Director TitleAgeSince
Director/Board Member 55 12/05/2008
Director/Board Member 67 20/09/2010
Chairman 64 20/05/2025
Date Insider Type Main position Quantity % Market Cap. Importance
30/09/26 Free

Director

958 0.0017%
04/09/26 Buy

Chief Administrative Officer

2,660 0.0047%
04/09/26 Buy

Chief Executive Officer

13,035 0.0228%
Change 5-day change 1-year change 3-year change Capi.($)
-0.62%+5.64%-36.12%-51.93% 1.22B
+0.89%+0.77%-17.55%+11.58% 179B
-0.84%+2.29%-20.58%+17.86% 118B
-1.01%+2.05%+0.57%+34.53% 117B
-3.26%+15.39%-44.57%+5.88% 93.26B
+0.57%-1.89%-0.73%+76.88% 63.16B
+0.04%+1.79%+13.52%+75.53% 55.68B
-1.89%+2.53%+4.56%-23.06% 54.18B
+1.35%+2.47%-12.03%+43.31% 44.15B
-0.07%+6.20%-4.23%-7.56% 33.95B
Average -0.48%+3.72%-11.71%+18.30% 75.96B
Weighted average by Cap. -0.48%+3.06%-12.41%+23.92%

Financials

2026 *2027 *
Net sales 2.34B 2.09B 1.93B 1.75B 3.27B 222B 3.33B 23.22B 9.19B 116B 8.78B 8.59B 367B 2.45B 2.19B 2.02B 1.83B 3.43B 233B 3.49B 24.36B 9.64B 122B 9.21B 9.01B 385B
Net income 11.38M 10.16M 9.38M 8.5M 15.91M 1.08B 16.17M 113M 44.71M 566M 42.69M 41.78M 1.78B 29.72M 26.54M 24.52M 22.22M 41.58M 2.82B 42.26M 295M 117M 1.48B 112M 109M 4.66B
Net Debt 1.31B 1.17B 1.08B 977M 1.83B 124B 1.86B 12.97B 5.13B 64.97B 4.9B 4.8B 205B 1.25B 1.11B 1.03B 931M 1.74B 118B 1.77B 12.36B 4.89B 61.93B 4.67B 4.57B 195B
Projected Income Statement - Annual - Enovis Corporation
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
26/10/26 US$21.01 -0.33% 183,895
23/10/26 US$21.08 -2.36% 954,300
22/10/26 US$21.59 +3.75% 1,295,357
21/10/26 US$20.81 +0.58% 1,204,040
20/10/26 US$20.69 +4.13% 1,185,246
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Enovis Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
21.08USD
Average target price
36.08USD
Spread / Average Target
+71.17%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Enovis Corporation
  1. Stock Market
  2. Stocks
  3. ENOV Stock